Bartlett & Co Wealth Management’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
YIH
ECM
PFSRSONJ
SCM
SS
TWC
Bartlett & Co Wealth Management's WHWK Position: Q2 2026 in Review
Bartlett & Co Wealth Management held its Whitehawk Therapeutics (WHWK) position steady in Q2 2026 at 1,333 shares worth $6.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1065.
Bartlett & Co Wealth Management first reported a position in WHWK in Q3 2022 and has held it in 16 quarters since. The position peaked at $18.8K in Q3 2022. 8 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.
- Bartlett & Co Wealth Management held 1,333 shares of Whitehawk Therapeutics worth $6.11K as of Q2 2026.
- Bartlett & Co Wealth Management left its Whitehawk Therapeutics share count unchanged in Q2 2026.
- Whitehawk Therapeutics made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #1065 holding.
- Bartlett & Co Wealth Management first reported a position in Whitehawk Therapeutics in Q3 2022 and has held it in 16 quarters since.
- Bartlett & Co Wealth Management's Whitehawk Therapeutics position peaked at $18.8K in Q3 2022.
- 8 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.